Ildong Holdings
Daily close in US$ at the latest USD/KRW close. Source: KRX via FinanceDataReader.
Ildong Holdings is a holding company, a parent entity that owns and oversees a group of operating subsidiaries, listed on KOSPI, Korea's main stock exchange.
Its business activities are conducted through those subsidiaries, which operate in the health-care sector, including pharmaceuticals and related services. Because the filing's business description sections contain no substantive detail, the precise products, customers, or supply-chain position of its underlying businesses cannot be confirmed from the available disclosure.
Summary is AI-generated and may contain errors · figures from DART filings
As a holding company, Ildong Holdings itself does not directly manufacture or distribute products; its financial results consolidate the performance of its operating subsidiaries.
Ildong Holdings in five facts
What does Ildong Holdings do?
Ildong Holdings is a holding company, a parent entity that owns and oversees a group of operating subsidiaries, listed on KOSPI, Korea's main stock exchange.
Where is Ildong Holdings listed and in which sector?
Ildong Holdings (Korean name: 일동홀딩스) trades under KRX code 000230 on KOSPI, the main board of the Korea Exchange. It is classified in the Health Care sector, Pharmaceuticals.
How large is Ildong Holdings?
Its market capitalisation was US$52.4M on 2026-10-21, which puts it in this site's small-cap group. US$ amounts are converted from won at 1 USD ≈ ₩1,325 (2026-10-21).
What were Ildong Holdings's latest annual revenue and operating profit?
For fiscal year 2025, Ildong Holdings reported revenue of US$446M, operating profit of US$11.3M and net income of US$16.3M, per its annual report on DART (data retrieved from DART on 2026-09-05). Revenue was down 10.1% on the previous year.
Where does this data come from?
Financial statements and filings come from DART, Korea's official corporate-filing system. Share prices, market capitalisation and trading status come from KRX. Company summaries are AI-generated from the filings and may contain errors; financial figures are mapped directly from DART.
Data sources and last updated
- Filings and financial statements
- DART (dart.fss.or.kr), Korea's official corporate-filing system
- Prices, market cap, trading status
- KRX (Korea Exchange), via FinanceDataReader
- Latest annual financials
- Fiscal year 2025, data retrieved from DART on 2026-09-05
- Share price and market cap
- Close of 2026-10-21
- Currency
- US$, converted from won at 1 USD ≈ ₩1,325 (2026-10-21 close)
- Company data updated
- 2026-10-21
- Company summary
- AI-generated from filings; may contain errors. Information only, not investment advice.
- [Amended] Material event reportSep 30
- [Amended] Material event reportSep 30
- Operating results (consolidated) (preliminary) (fair disclosure)
Ildong Holdings filed provisional (unaudited) consolidated results for Q2 2026: revenue of US$111M (+8.3% year on year), operating profit of US$3.54M (from a loss a year earlier) and net income of US$3.98M (from a loss a year earlier).
Earnings · Jul 30 - Operating results (consolidated) (preliminary) (fair disclosure)
Ildong Holdings filed provisional (unaudited) consolidated results for Q1 2026: revenue of US$99.9M (−0.6% year on year), operating profit of US$5.97M (+117.5% year on year) and net income of US$3.88M (from a loss a year earlier).
Earnings · May 13 - Merger decision (subsidiary)M&A · Apr 13
- Cash/in-kind dividend decision
Ildong Holdings declared a cash dividend of US$0.07 per share.
Dividend · Feb 11 - Operating results (consolidated) (preliminary) (fair disclosure)
Ildong Holdings filed provisional (unaudited) consolidated results for Q4 2025: revenue of US$106M (−4.1% year on year), operating profit of US$4.97M (+85.7% year on year) and net income of US$10.3M (−82% year on year).
Earnings · Feb 11 - Change of 30% or more in revenue or profit/loss structure (15% for large companies)
Ildong Holdings reported consolidated results for FY2025: revenue of US$405M (−6.9% year on year), operating profit of US$10.2M (from a loss a year earlier) and net income of US$13.6M (−64.3% year on year).
Earnings · Feb 5